Despite advances in cytotoxic treatments, colorectal cancer remains a leading cause of
death. Metastatic colorectal cancer (mCRC) patients have a poor prognosis despite …

Resistance to anoikis is a key characteristic of many cancer cells, promoting cell survival.
However, the mechanism of anoikis in hepatocellular carcinoma (HCC) remains unknown …

Hepatocellular carcinoma (HCC) is a liver cancer, highly heterogeneous both at the
histopathological and molecular levels. It arises from hepatocytes as the result of the …

Background: Peptidyl-prolyl isomerase H (PPIH) is a member of the cyclophilin protein
family, which functions as a molecular chaperone and is involved in the splicing of pre …

MiR-181 expression levels increased in hepatocellular carcinoma (HCC) compared to non-
cancerous tissues. MiR-181 has been widely reported as a possible driver of …

Hepatocellular carcinoma (HCC) is a malignant tumor that arises from hepatocytes. Multiple
signaling pathways play a regulatory role in the occurrence and development of HCC, with …

Background Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related
mortality worldwide. It is a highly heterogeneous disease with poor prognosis and limited …

Liver cancer refers primarily to hepatocellular carcinoma (HCC) accounting for over 90% of
cases and is the highest incidence in men in Thailand. Over the past decades, the incidence …

Studies have demonstrated that autoantibodies to tumor-associated antigens (TAAs) may be
used as efficient biomarkers with low-cost and highly sensitive characteristics. In this study …

In cancer treatment, therapeutic strategies that integrate tumor-specific characteristics (ie,
precision oncology) are widely implemented to provide clinical benefits for cancer patients …